Hologic Balance Sheet Health
Financial Health criteria checks 6/6
Hologic has a total shareholder equity of $5.0B and total debt of $2.5B, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are $8.9B and $3.9B respectively. Hologic's EBIT is $940.0M making its interest coverage ratio 447.6. It has cash and short-term investments of $2.4B.
Key information
51.4%
Debt to equity ratio
US$2.54b
Debt
| Interest coverage ratio | 447.6x |
| Cash | US$2.45b |
| Equity | US$4.95b |
| Total liabilities | US$3.94b |
| Total assets | US$8.89b |
Recent financial health updates
These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well
Jun 20
Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet
Mar 20We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Nov 08We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Jul 31We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Apr 25Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly
Jan 18Recent updates
Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar
Sep 01Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them
Aug 27Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?
Jul 21These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well
Jun 20Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down
May 22Hologic: Women's Health Play Looks Healthier Itself
May 13Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult
Apr 19Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)
Apr 05Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet
Mar 20Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Feb 22Hologic: Prospects For Growth As Headwinds Disappear
Feb 11We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings
Feb 09Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next
Feb 06We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)
Jan 29The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)
Dec 30Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?
Dec 11We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Nov 08Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?
Oct 25Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement
Sep 28Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price
Aug 29We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Jul 31Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Jul 18Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing
Jun 21Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
May 22We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Apr 25What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?
Apr 10Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher
Mar 13Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
Feb 14Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly
Jan 18Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?
Jan 03Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns
Dec 02Financial Position Analysis
Short Term Liabilities: HOLX's short term assets ($4.0B) exceed its short term liabilities ($1.0B).
Long Term Liabilities: HOLX's short term assets ($4.0B) exceed its long term liabilities ($2.9B).
Debt to Equity History and Analysis
Debt Level: HOLX's net debt to equity ratio (1.9%) is considered satisfactory.
Reducing Debt: HOLX's debt to equity ratio has reduced from 137.8% to 51.4% over the past 5 years.
Debt Coverage: HOLX's debt is well covered by operating cash flow (46.3%).
Interest Coverage: HOLX's interest payments on its debt are well covered by EBIT (447.6x coverage).